Soy isoflavones reduce asthma exacerbation in asthmatics with high PAI-1 producing genotypes

The soy isoflavone treatment significantly reduced the number of severe asthma exacerbations in asthmatic subjects with the high PAI-1 producing genotypes, suggesting PAI-1 polymorphisms as a genetic biomarker for soy isoflavone responsive asthma. (Source: Journal of Allergy and Clinical Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2B9j9sW